glomerulosclerosis 3: 192
hemolytic uremic syndrome
3: 195
hyperoxaluria 3: 197
nephropathy 3: 210
polycystic kidney disease 3: 214
uremia 3: 221
urinary system 3: 174
killer T-cell 2:272, 296
Klinefelter’s syndrome 3:291, 294,
296; 4: 117
knee injuries 1:330–332, 331 t,
332 t;4: 211
Baker’s cyst 1:307
meniscectomy 1:336
neurogenic arthropathy 1: 340
Osgood-Schlatter disease 1: 341
patellofemoral syndrome
1:348–349
Kupffer cells 2:119, 138, 157, 162
kyphosis 1: 298 , 332, 345
L
labyrinth 4:79, 91
labyrinthitis 1:31
lacerations 4:265, 274, 361, 362,
365–366,366, 379–380
lacrimal (tear) ducts 1:85, 86
lacrimal (tear) glands (Sjögren’s
syndrome) 2:294–295
lactase 4:180, 185
lactation 3:139, 250
lactiferous glands 3:250, 253
lactose intolerance 4: 180 , 185
LAD artery. Seeleft anterior
descending artery
laminectomy 1:333
Landsteiner, Karl 2:122, 130
Langerhans cells 1:127; 2:157, 295
Langer’s lines 4:265
language disorders (aphasia) 1:225
laparoscopic surgery 3:14–15, 22,
47, 206; 4:286, 287
laryngeal cancer 4:306, 353
laryngectomy 1:21, 23, 31–32, 64
laryngitis 1:32, 64
laryngocele 1:32
larynx 1:13, 21, 31–32, 57, 63–64
laser skin resurfacing 1:172, 210
laser surgery 1:71, 108, 111–112,
114; 2:111–112, 115; 4:265–266,
266 , 266 t
laser therapy 1:192, 203
LASIK (laser-assisted in situ
keratomileusis) eye surgery 1:69,
109, 111, 112
laxatives 3: 32 , 68–69, 68 t, 374
lazy eye. Seeamblyopia
LDL-C. Seelow-density lipoprotein
cholesterol
lean muscle mass 4:215, 222, 226,
233, 288–290, 293, 297, 307
learning disorders 1: 54 , 258–259;
4:313, 329
left anterior descending (LAD)
artery 2:40, 43
left atrium 2:4, 62, 88
left ventricle 2:4, 32, 40, 112
left ventricular ejection fraction
(LVEF) 2:45, 61, 72
legal blindness 1:67, 122, 122t,
123 t
legend drug 4:161
Legionella pneumophila2:206, 303
Legionnaires’ disease 1: 42 t;
2:206–207, 222 , 303
legs 2:69, 96–97, 114–116, 225;
4: 45
lens 1:77–79, 82, 89, 100, 108
lens replacement 1:78, 112
lentigines 1: 134 , 172–173
lesion 1:173, 173 t
acne 1: 131
actinic keratosis 1:133–134
erythema multiforme 1: 156
ichthyosis 1: 166
Kaposi’s sarcoma 1: 168
keratoacanthoma 1: 170
macule 1:175
nevus 1:178–179
petechiae 1:183
pityriasis rosea 1: 186
plaque, skin 1:186
prurigo 1:186–187
psoriasis 1:188, 189
purpura 1:190
scale 1:194
scar 1: 194
seborrheic keratosis 1: 195
staphylococcal scalded skin
syndrome 1: 200
thrush 1: 58
vesicle 1:207
wheal 1:209–210
xanthoma 1:211
letdown reflex 3: 152 , 296
leukemia 1:150; 2:145–148, 147 t
adult survivors of childhood
cancer 2:366, 367
B-cell lymphocyte 2: 251
blood and lymph research and
treatment advances 2: 122blood disorders 2: 121
bone marrow donation 2: 132
cancer treatment options and
decisions 2: 372
carcinogen 2: 374
cell structure and function
4: 115
chemotherapy 2: 377
CSFs 2: 254
immunoglobulin 2: 275
interferons 2: 278
lymphadenopathy 2: 149
lymphoma 2: 155
multiple myeloma 2: 159
pericarditis 2: 95
stem cell therapy 4: 141
leukocyte 2:148, 148 t
aging and changes in
blood/lymph 2: 123
antibody 2: 245
antihistamine medications
2: 247
B-cell lymphocyte 2:251
blood and lymph 2:118,
119–120
bone marrow 2: 132
chemokines 2: 253
corticosteroid medications 2: 257
CSFs 2: 254
cytokines 2: 257
food allergies 2: 260
graft vs. host disease 2: 263
granulocyte 2: 138
human ehrlichiosis 2:335, 336
immunodeficiency 2: 274
immunotherapy 2: 276
interleukins 2: 278
leukopenia 2: 148
lymph 2: 120
lymphocyte 2: 151
lymphoma 2: 152
mast cell 2:283
monocyte 2: 157
necrotizing fasciitis 2: 346
PCID 2: 289
phagocyte 2: 162
SCID 2: 294
T-cell lymphocyte 2:296
TNFs 2: 297
leukopenia 2:148, 152
leukoplakia 1:32
leukotrienes 2:138, 240, 258, 260,
279, 290
levo-alpha acetylmethadol (LAAM)
4:342, 354
Lewy body dementia 1:251, 252Index 483